当前位置: X-MOL 学术Alzheimers Dement. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Relationship of serum beta-synuclein with blood biomarkers and brain atrophy
Alzheimer's & Dementia ( IF 13.0 ) Pub Date : 2022-09-21 , DOI: 10.1002/alz.12790
Patrick Oeckl 1, 2 , Sarah Anderl-Straub 1 , Adrian Danek 3 , Janine Diehl-Schmid 4 , Klaus Fassbender 5 , Klaus Fliessbach 6 , Steffen Halbgebauer 1 , Hans-Jürgen Huppertz 7 , Holger Jahn 8 , Jan Kassubek 1, 2 , Johannes Kornhuber 9 , Bernhard Landwehrmeyer 1 , Martin Lauer 10 , Johannes Prudlo 11 , Anja Schneider 6 , Matthias L Schroeter 12 , Petra Steinacker 1 , Alexander E Volk 13 , Matias Wagner 14 , Juliane Winkelmann 14 , Jens Wiltfang 15 , Albert C Ludolph 1, 2 , Markus Otto 1, 16 ,
Affiliation  

Recent data support beta-synuclein as a blood biomarker to study synaptic degeneration in Alzheimer's disease (AD).

中文翻译:

血清β-突触核蛋白与血液生物标志物和脑萎缩的关系

最近的数据支持将 β-突触核蛋白作为血液生物标志物来研究阿尔茨海默病 (AD) 中的突触退化。
更新日期:2022-09-21
down
wechat
bug